TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bioform AB
Closing information (x1000 EUR)
Closing information | 2023/08 | 2022/08 | 2021/08 |
Turnover | 111 | 144 | 145 |
Financial expenses | 1 | 1 | 0 |
Earnings before taxes | 42 | 44 | 49 |
EBITDA | 46 | 49 | 49 |
Total assets | 174 | 213 | 205 |
Current assets | 161 | 154 | 157 |
Current liabilities | 10 | 15 | 14 |
Equity capital | 151 | 148 | 136 |
- share capital | 8 | 9 | 10 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2023/08 | 2022/08 | 2021/08 |
Solvency | 86.8% | 69.5% | 66.3% |
Turnover per employee | 111 | 144 | 145 |
Profit as a percentage of turnover | 37.8% | 30.6% | 33.8% |
Return on assets (ROA) | 24.7% | 21.1% | 23.9% |
Current ratio | 1610.0% | 1026.7% | 1121.4% |
Return on equity (ROE) | 27.8% | 29.7% | 36.0% |
Change turnover | -19 | 6 | 2 |
Change turnover % | -15% | 4% | 1% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/08 | 2022/08 | 2021/08 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.